Acute ischemic stroke intervention linked to poor functional outcomes

Takeaway

  • Natalizumab is associated with poorer neurologic outcomes in people with acute ischemic stroke (AIS).

Why this matters

    Natalizumab should not be recommended as a treatment in cases of AIS.